Previous studies indicated that ZBTB4 and PDGFRA played roles in tumor progression, same as our prediction (Kim et al., 2012; Kang et al., 2015; Roussel-Gervais et al., 2017; Yu Y. et al., 2018; Ye et al., 2019). This evidence concerns the gene ZBTB4 and neoplasm.